|
1
|
Bedoui S, Herold MJ and Strasser A:
Emerging connectivity of programmed cell death pathways and its
physiological implications. Nat Rev Mol Cell Biol. 21:678–695.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Newton K, Strasser A, Kayagaki N and Dixit
VM: Cell death. Cell. 187:235–256. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malireddi RKS, Kesavardhana S and
Kanneganti TD: ZBP1 and TAK1: Master regulators of NLRP3
inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis).
Front Cell Infect Microbiol. 9:4062019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pandian N and Kanneganti TD: PANoptosis: A
unique innate immune inflammatory cell death modality. J Immunol.
209:1625–1633. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Y, Pandian N, Han JH, Sundaram B, Lee
S, Karki R, Guy CS and Kanneganti TD: Single cell analysis of
PANoptosome cell death complexes through an expansion microscopy
method. Cell Mol Life Sci. 79:5312022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie H, Liang B, Zhu Q, Wang L, Li H, Qin
Z, Zhang J, Liu Z and Wu Y: The role of PANoptosis in renal
vascular endothelial cells: Implications for
trichloroethylene-induced kidney injury. Ecotoxicol Environ Saf.
278:1164332024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mall R and Kanneganti TD: Comparative
analysis identifies genetic and molecular factors associated with
prognostic clusters of PANoptosis in glioma, kidney and melanoma
cancer. Sci Rep. 13:209622023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Uysal E, Dokur M, Kucukdurmaz F, Altınay
S, Polat S, Batcıoglu K, Sezgın E, Sapmaz Erçakallı T, Yaylalı A,
Yılmaztekin Y, et al: Targeting the PANoptosome with 3,4-meth
ylenedioxy-β-nitrostyrene, reduces PANoptosis and protects the
kidney against renal ischemia-reperfusion injury. J Invest Surg.
35:1824–1835. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang Z, Wang J, Dao C, Zhu M, Li Y, Liu
F, Zhao Y, Li J, Yang Y and Pan Z: Utilizing a novel model of
PANoptosis-related genes for enhanced prognosis and immune status
prediction in kidney renal clear cell carcinoma. Apoptosis.
29:681–692. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yi BJ, Wang CC, Li XW, Xu YR, Ma XY, Jian
PA, Talukder M, Li XN and Li JL: Lycopene protects against
atrazine-induced kidney STING-dependent panoptosis through
stabilizing mtDNA via interaction with Sam50/PHB1. J Agric Food
Chem. 72:14956–14966. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li YP, Zhou ZY, Yan L, You YP, Ke HY, Yuan
T, Yang HY, Xu R, Xu LH, Ouyang DY, et al: Inflammatory cell death
PANoptosis is induced by the anti-cancer curaxin CBL0137 via
eliciting the assembly of ZBP1-associated PANoptosome. Inflamm Res.
73:597–617. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karki R, Sharma BR, Lee E, Banoth B,
Malireddi RKS, Samir P, Tuladhar S, Mummareddy H, Burton AR, Vogel
P and Kanneganti TD: Interferon regulatory factor 1 regulates
PANoptosis to prevent colorectal cancer. JCI Insight.
5:e1367202020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kroemer G: The pharmacology of T cell
apoptosis. Adv Immunol. 58:211–296. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsujimoto Y: Role of Bcl-2 family proteins
in apoptosis: Apoptosomes or mitochondria? Genes Cells. 3:697–707.
1998. View Article : Google Scholar
|
|
16
|
Li PF, Dietz R and von Harsdorf R: p53
regulates mitochondrial membrane potential through reactive oxygen
species and induces cytochrome c-independent apoptosis blocked by
Bcl-2. EMBO J. 18:6027–6036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View Article : Google Scholar
|
|
18
|
Kalkavan H and Green DR: MOMP, cell
suicide as a BCL-2 family business. Cell Death Differ. 25:46–55.
2018. View Article : Google Scholar
|
|
19
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hengartner MO and Horvitz HR: The ins and
outs of programmed cell death during C. elegans development. Philos
Trans R Soc Lond B Biol Sci. 345:243–246. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fox JL, Hughes MA, Meng X, Sarnowska NA,
Powley IR, Jukes-Jones R, Dinsdale D, Ragan TJ, Fairall L, Schwabe
JWR, et al: Cryo-EM structural analysis of FADD:Caspase-8 complexes
defines the catalytic dimer architecture for co-ordinated control
of cell fate. Nat Commun. 12:8192021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu TM, Li Y, Lu A, Li Z, Vajjhala PR, Cruz
AC, Srivastava DB, DiMaio F, Penczek PA, Siegel RM, et al: Cryo-EM
structure of caspase-8 tandem DED filament reveals assembly and
regulation mechanisms of the death-inducing signaling complex. Mol
Cell. 64:236–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feoktistova M, Geserick P, Kellert B,
Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, Häcker G
and Leverkus M: cIAPs block Ripoptosome formation, a RIP1/caspase-8
containing intracellular cell death complex differentially
regulated by cFLIP isoforms. Mol Cell. 43:449–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carneiro BA and El-Deiry WS: Targeting
apoptosis in cancer therapy. Nat Rev Clin Oncol. 17:395–417. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Van Opdenbosch N and Lamkanfi M: Caspases
in cell death, inflammation, and disease. Immunity. 50:1352–1364.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seol DW, Li J, Seol MH, Park SY, Talanian
RV and Billiar TR: Signaling events triggered by tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL): Caspase-8 is
required for TRAIL-induced apoptosis. Cancer Res. 61:1138–1143.
2001.PubMed/NCBI
|
|
28
|
Degterev A, Huang Z, Boyce M, Li Y, Jagtap
P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J:
Chemical inhibitor of nonapoptotic cell death with therapeutic
potential for ischemic brain injury. Nat Chem Biol. 1:112–119.
2005. View Article : Google Scholar
|
|
29
|
Khoury MK, Gupta K, Franco SR and Liu B:
Necroptosis in the pathophysiology of disease. Am J Pathol.
190:272–285. 2020. View Article : Google Scholar :
|
|
30
|
Weinlich R, Oberst A, Beere HM and Green
DR: Necroptosis in development, inflammation and disease. Nat Rev
Mol Cell Biol. 18:127–136. 2017. View Article : Google Scholar
|
|
31
|
Murphy JM: The killer pseudokinase mixed
lineage kinase domain-like protein (MLKL). Cold Spring Harb
Perspect Biol. 12:a0363762020. View Article : Google Scholar
|
|
32
|
Petrie EJ, Sandow JJ, Lehmann WIL, Liang
LY, Coursier D, Young SN, Kersten WJA, Fitzgibbon C, Samson AL,
Jacobsen AV, et al: Viral MLKL homologs subvert necroptotic cell
death by sequestering cellular RIPK3. Cell Rep. 28:3309–3319.e5.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holler N, Zaru R, Micheau O, Thome M,
Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp
J: Fas triggers an alternative, caspase-8-independent cell death
pathway using the kinase RIP as effector molecule. Nat Immunol.
1:489–495. 2000. View
Article : Google Scholar
|
|
34
|
He S, Liang Y, Shao F and Wang X:
Toll-like receptors activate programmed necrosis in macrophages
through a receptor-interacting kinase-3-mediated pathway. Proc Natl
Acad Sci USA. 108:20054–20059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kaiser WJ, Sridharan H, Huang C, Mandal P,
Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J and Mocarski ES:
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J
Biol Chem. 288:31268–31279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang T, Wang Y, Inuzuka H and Wei W:
Necroptosis pathways in tumorigenesis. Semin Cancer Biol. 86:32–40.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cho YS, Challa S, Moquin D, Genga R, Ray
TD, Guildford M and Chan FK: Phosphorylation-driven assembly of the
RIP1-RIP3 complex regulates programmed necrosis and virus-induced
inflammation. Cell. 137:1112–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vanden Berghe T, Kaiser WJ, Bertrand MJ
and Vandenabeele P: Molecular crosstalk between apoptosis,
necroptosis, and survival signaling. Mol Cell Oncol. 2:e9750932015.
View Article : Google Scholar
|
|
39
|
Wong WW, Gentle IE, Nachbur U, Anderton H,
Vaux DL and Silke J: RIPK1 is not essential for TNFR1-induced
activation of NF-kappaB. Cell Death Differ. 17:482–487. 2010.
View Article : Google Scholar
|
|
40
|
Wang H, Sun L, Su L, Rizo J, Liu L, Wang
LF, Wang FS and Wang X: Mixed lineage kinase domain-like protein
MLKL causes necrotic membrane disruption upon phosphorylation by
RIP3. Mol Cell. 54:133–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cai Z, Jitkaew S, Zhao J, Chiang HC,
Choksi S, Liu J, Ward Y, Wu LG and Liu ZG: Plasma membrane
translocation of trimerized MLKL protein is required for
TNF-induced necroptosis. Nat Cell Biol. 16:55–65. 2014. View Article : Google Scholar
|
|
42
|
Robinson N, McComb S, Mulligan R, Dudani
R, Krishnan L and Sad S: Type I interferon induces necroptosis in
macrophages during infection with Salmonella enterica serovar
Typhimurium. Nat Immunol. 13:954–962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McComb S, Cessford E, Alturki NA, Joseph
J, Shutinoski B, Startek JB, Gamero AM, Mossman KL and Sad S:
Type-I interferon signaling through ISGF3 complex is required for
sustained Rip3 activation and necroptosis in macrophages. Proc Natl
Acad Sci USA. 111:E3206–E3213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xia B, Fang S, Chen X, Hu H, Chen P, Wang
H and Gao Z: MLKL forms cation channels. Cell Res. 26:517–528.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Negroni A, Colantoni E, Cucchiara S and
Stronati L: Necroptosis in intestinal inflammation and cancer: New
concepts and therapeutic perspectives. Biomolecules. 10:14312020.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Woo Y, Lee HJ, Jung YM and Jung YJ:
Regulated necrotic cell death in alternative tumor therapeutic
strategies. Cells. 9:27092020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zychlinsky A, Prevost MC and Sansonetti
PJ: Shigella flexneri induces apoptosis in infected macrophages.
Nature. 358:167–169. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hilbi H, Moss JE, Hersh D, Chen Y, Arondel
J, Banerjee S, Flavell RA, Yuan J, Sansonetti PJ and Zychlinsky A:
Shigella-induced apoptosis is dependent on caspase-1 which binds to
IpaB. J Biol Chem. 273:32895–32900. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cookson BT and Brennan MA:
Pro-inflammatory programmed cell death. Trends Microbiol.
9:113–114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wallach D, Kang TB, Dillon CP and Green
DR: Programmed necrosis in inflammation: Toward identification of
the effector molecules. Science. 352:aaf21542016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Atabaki R, Khaleghzadeh-Ahangar H,
Esmaeili N and Mohseni-Moghaddam P: Role of pyroptosis, a
pro-inflammatory programmed cell death, in epilepsy. Cell Mol
Neurobiol. 43:1049–1059. 2023. View Article : Google Scholar
|
|
53
|
Bergsbaken T, Fink SL and Cookson BT:
Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol.
7:99–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rathinam VAK, Vanaja SK, Waggoner L,
Sokolovska A, Becker C, Stuart LM, Leong JM and Fitzgerald KA: TRIF
licenses caspase-11-dependent NLRP3 inflammasome activation by
gram-negative bacteria. Cell. 150:606–619. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fritsch M, Günther SD, Schwarzer R, Albert
MC, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H,
Seeger JM, et al: Caspase-8 is the molecular switch for apoptosis,
necroptosis and pyroptosis. Nature. 575:683–687. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gurung P, Anand PK, Malireddi RK, Vande
Walle L, Van Opdenbosch N, Dillon CP, Weinlich R, Green DR,
Lamkanfi M and Kanneganti TD: FADD and caspase-8 mediate priming
and activation of the canonical and noncanonical Nlrp3
inflammasomes. J Immunol. 192:1835–1846. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Man SM, Tourlomousis P, Hopkins L, Monie
TP, Fitzgerald KA and Bryant CE: Salmonella infection induces
recruitment of caspase-8 to the inflammasome to modulate IL-1β
production. J Immunol. 191:5239–5246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Van Opdenbosch N, Van Gorp H, Verdonckt M,
Saavedra PHV, de Vasconcelos NM, Gonçalves A, Vande Walle L, Demon
D, Matusiak M, Van Hauwermeiren F, et al: Caspase-1 engagement and
TLR-induced c-FLIP expression suppress ASC/caspase-8-dependent
apoptosis by inflammasome sensors NLRP1b and NLRC4. Cell Rep.
21:3427–3444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Park MY, Ha SE, Vetrivel P, Kim HH,
Bhosale PB, Abusaliya A and Kim GS: Differences of key proteins
between apoptosis and necroptosis. Biomed Res Int.
2021:34201682021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Newton K, Wickliffe KE, Dugger DL,
Maltzman A, Roose-Girma M, Dohse M, Kőműves L, Webster JD and Dixit
VM: Cleavage of RIPK1 by caspase-8 is crucial for limiting
apoptosis and necroptosis. Nature. 574:428–431. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Vandenabeele P, Galluzzi L, Vanden Berghe
T and Kroemer G: Molecular mechanisms of necroptosis: An ordered
cellular explosion. Nat Rev Mol Cell Biol. 11:700–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Schwarzer R, Laurien L and Pasparakis M:
New insights into the regulation of apoptosis, necroptosis, and
pyroptosis by receptor interacting protein kinase 1 and caspase-8.
Curr Opin Cell Biol. 63:186–193. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hsu H, Shu HB, Pan MG and Goeddel DV:
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF
receptor 1 signal transduction pathways. Cell. 84:299–308. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Dillon CP, Weinlich R, Rodriguez DA,
Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F,
Gong YN, et al: RIPK1 blocks early postnatal lethality mediated by
caspase-8 and RIPK3. Cell. 157:1189–1202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Orning P, Weng D, Starheim K, Ratner D,
Best Z, Lee B, Brooks A, Xia S, Wu H, Kelliher MA, et al: Pathogen
blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin
D and cell death. Science. 362:1064–1069. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Sarhan J, Liu BC, Muendlein HI, Li P,
Nilson R, Tang AY, Rongvaux A, Bunnell SC, Shao F, Green DR and
Poltorak A: Caspase-8 induces cleavage of gasdermin D to elicit
pyroptosis during Yersinia infection. Proc Natl Acad Sci USA.
115:E10888–E10897. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu
JM, Nie L, Chen Y, Wang YC, Liu C, et al: PD-L1-mediated gasdermin
C expression switches apoptosis to pyroptosis in cancer cells and
facilitates tumour necrosis. Nat Cell Biol. 22:1264–1275. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang Y, Karki R, Zheng M, Kancharana B,
Lee S, Kesavardhana S, Hansen BS, Pruett-Miller SM and Kanneganti
TD: Cutting edge: Caspase-8 is a linchpin in caspase-3 and
gasdermin D activation to control cell death, cytokine release, and
host defense during influenza A virus infection. J Immunol.
207:2411–2416. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Rogers C, Fernandes-Alnemri T, Mayes L,
Alnemri D, Cingolani G and Alnemri ES: Cleavage of DFNA5 by
caspase-3 during apoptosis mediates progression to secondary
necrotic/pyroptotic cell death. Nat Commun. 8:141282017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang Y, Gao W, Shi X, Ding J, Liu W, He H,
Wang K and Shao F: Chemotherapy drugs induce pyroptosis through
caspase-3 cleavage of a gasdermin. Nature. 547:99–103. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Tsuchiya K, Nakajima S, Hosojima S, Thi
Nguyen D, Hattori T, Manh Le T, Hori O, Mahib MR, Yamaguchi Y,
Miura M, et al: Caspase-1 initiates apoptosis in the absence of
gasdermin D. Nat Commun. 10:20912019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lamkanfi M, Kanneganti TD, Van Damme P,
Vanden Berghe T, Vanoverberghe I, Vandekerckhove J, Vandenabeele P,
Gevaert K and Núñez G: Targeted peptidecentric proteomics reveals
caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell
Proteomics. 7:2350–2363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Conos SA, Chen KW, De Nardo D, Hara H,
Whitehead L, Núñez G, Masters SL, Murphy JM, Schroder K, Vaux DL,
et al: Active MLKL triggers the NLRP3 inflammasome in a
cell-intrinsic manner. Proc Natl Acad Sci USA. 114:E961–E969. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gutierrez KD, Davis MA, Daniels BP, Olsen
TM, Ralli-Jain P, Tait SW, Gale M Jr and Oberst A: MLKL activation
triggers NLRP3-mediated processing and release of IL-1β
independently of gasdermin-D. J Immunol. 198:2156–2164. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Muñoz-Planillo R, Kuffa P, Martínez-Colón
G, Smith BL, Rajendiran TM and Núñez G: K+ efflux is the
common trigger of NLRP3 inflammasome activation by bacterial toxins
and particulate matter. Immunity. 38:1142–1153. 2013. View Article : Google Scholar
|
|
76
|
Lawlor KE, Khan N, Mildenhall A, Gerlic M,
Croker BA, D'Cruz AA, Hall C, Kaur Spall S, Anderton H, Masters SL,
et al: RIPK3 promotes cell death and NLRP3 inflammasome activation
in the absence of MLKL. Nat Commun. 6:62822015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Malireddi RKS, Gurung P, Mavuluri J,
Dasari TK, Klco JM, Chi H and Kanneganti TD: TAK1 restricts
spontaneous NLRP3 activation and cell death to control myeloid
proliferation. J Exp Med. 215:1023–1034. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zheng M, Karki R, Vogel P and Kanneganti
TD: Caspase-6 is a key regulator of innate immunity, inflammasome
activation, and host defense. Cell. 181:674–687.e13. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Malireddi RKS, Gurung P, Kesavardhana S,
Samir P, Burton A, Mummareddy H, Vogel P, Pelletier S, Burgula S
and Kanneganti TD: Innate immune priming in the absence of TAK1
drives RIPK1 kinase activity-independent pyroptosis, apoptosis,
necroptosis, and inflammatory disease. J Exp Med.
217:jem.201916442020. View Article : Google Scholar
|
|
80
|
Christgen S, Tweedell RE and Kanneganti
TD: Programming inflammatory cell death for therapy. Pharmacol
Ther. 232:1080102022. View Article : Google Scholar :
|
|
81
|
Tweedell RE and Kanneganti TD: Advances in
inflammasome research: Recent breakthroughs and future hurdles.
Trends Mol Med. 26:969–971. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Lee S, Karki R, Wang Y, Nguyen LN,
Kalathur RC and Kanneganti TD: AIM2 forms a complex with pyrin and
ZBP1 to drive PANoptosis and host defence. Nature. 597:415–419.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Shi C, Cao P, Wang Y, Zhang Q, Zhang D,
Wang Y, Wang L and Gong Z: PANoptosis: A cell death characterized
by pyroptosis, apoptosis, and necroptosis. J Inflamm Res.
16:1523–1532. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Banoth B, Tuladhar S, Karki R, Sharma BR,
Briard B, Kesavardhana S, Burton A and Kanneganti TD: ZBP1 promotes
fungi-induced inflammasome activation and pyroptosis, apoptosis,
and necroptosis (PANoptosis). J Biol Chem. 295:18276–18283. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Kesavardhana S, Malireddi RKS, Burton AR,
Porter SN, Vogel P, Pruett-Miller SM and Kanneganti TD: The Zα2
domain of ZBP1 is a molecular switch regulating influenza-induced
PANoptosis and perinatal lethality during development. J Biol Chem.
295:8325–8330. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Karki R, Lee S, Mall R, Pandian N, Wang Y,
Sharma BR, Malireddi RS, Yang D, Trifkovic S, Steele JA, et al:
ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine
storm disrupt IFN therapeutic efficacy during coronavirus
infection. Sci Immunol. 7:eabo62942022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Malireddi RKS, Kesavardhana S, Karki R,
Kancharana B, Burton AR and Kanneganti TD: RIPK1 distinctly
regulates Yersinia-induced inflammatory cell death, PANoptosis.
Immunohorizons. 4:789–796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sundaram B, Pandian N, Mall R, Wang Y,
Sarkar R, Kim HJ, Malireddi RKS, Karki R, Janke LJ, Vogel P and
Kanneganti TD: NLRP12-PANoptosome activates PANoptosis and
pathology in response to heme and PAMPs. Cell. 186:2783–2801.e20.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kuriakose T, Man SM, Malireddi RK, Karki
R, Kesavardhana S, Place DE, Neale G, Vogel P and Kanneganti TD:
ZBP1/DAI is an innate sensor of influenza virus triggering the
NLRP3 inflammasome and programmed cell death pathways. Sci Immunol.
1:aag20452016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Rebsamen M, Heinz LX, Meylan E, Michallet
MC, Schroder K, Hofmann K, Vazquez J, Benedict CA and Tschopp J:
DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction
motifs to activate NF-kappaB. EMBO Rep. 10:916–922. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Upton JW, Kaiser WJ and Mocarski ES:
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced
programmed necrosis that is targeted by murine cytomegalovirus
vIRA. Cell Host Microbe. 11:290–297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Kuriakose T and Kanneganti TD: ZBP1:
Innate sensor regulating cell death and inflammation. Trends
Immunol. 39:123–134. 2018. View Article : Google Scholar :
|
|
93
|
Thapa RJ, Ingram JP, Ragan KB, Nogusa S,
Boyd DF, Benitez AA, Sridharan H, Kosoff R, Shubina M, Landsteiner
VJ, et al: DAI senses influenza A virus genomic RNA and activates
RIPK3-dependent cell death. Cell Host Microbe. 20:674–681. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zheng M and Kanneganti TD: Newly
identified function of caspase-6 in ZBP1-mediated innate immune
responses, NLRP3 inflammasome activation, PANoptosis, and host
defense. J Cell Immunol. 2:341–347. 2020.
|
|
95
|
Momota M, Lelliott P, Kubo A, Kusakabe T,
Kobiyama K, Kuroda E, Imai Y, Akira S, Coban C and Ishii KJ: ZBP1
governs the inflammasome-independent IL-1α and neutrophil
inflammation that play a dual role in anti-influenza virus
immunity. Int Immunol. 32:203–212. 2020. View Article : Google Scholar
|
|
96
|
Hornung V, Ablasser A, Charrel-Dennis M,
Bauernfeind F, Horvath G, Caffrey DR, Latz E and Fitzgerald KA:
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating
inflammasome with ASC. Nature. 458:514–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Bürckstümmer T, Baumann C, Blüml S, Dixit
E, Dürnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett
KL and Superti-Furga G: An orthogonal proteomic-genomic screen
identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome.
Nat Immunol. 10:266–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Fernandes-Alnemri T, Yu JW, Datta P, Wu J
and Alnemri ES: AIM2 activates the inflammasome and cell death in
response to cytoplasmic DNA. Nature. 458:509–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Fernandes-Alnemri T, Yu JW, Juliana C,
Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott
E, et al: The AIM2 inflammasome is critical for innate immunity to
Francisella tularensis. Nat Immunol. 11:385–393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Rathinam VA, Jiang Z, Waggoner SN, Sharma
S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et
al: The AIM2 inflammasome is essential for host defense against
cytosolic bacteria and DNA viruses. Nat Immunol. 11:395–402. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Vanden Berghe T, Linkermann A,
Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis:
The expanding network of non-apoptotic cell death pathways. Nat Rev
Mol Cell Biol. 15:135–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kist M, Kőműves LG, Goncharov T, Dugger
DL, Yu C, Roose-Girma M, Newton K, Webster JD and Vucic D: Impaired
RIPK1 ubiquitination sensitizes mice to TNF toxicity and
inflammatory cell death. Cell Death Differ. 28:985–1000. 2021.
View Article : Google Scholar :
|
|
103
|
Mihaly SR, Ninomiya-Tsuji J and Morioka S:
TAK1 control of cell death. Cell Death Differ. 21:1667–1676. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Sanjo H, Nakayama J, Yoshizawa T, Fehling
HJ, Akira S and Taki S: Cutting edge: TAK1 safeguards macrophages
against proinflammatory cell death. J Immunol. 203:783–788. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Malireddi RKS, Tweedell RE and Kanneganti
TD: PANoptosis components, regulation, and implications. Aging
(Albany NY). 12:11163–11164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kanneganti TD: Intracellular innate immune
receptors: Life inside the cell. Immunol Rev. 297:5–12. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ostermann M, Basu RK and Mehta RL: Acute
kidney injury. Intensive Care Med. 49:219–222. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ostermann M, Lumlertgul N, Jeong R, See E,
Joannidis M and James M: Acute kidney injury. Lancet. 405:241–256.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wu C, Zhang Y, Nie S, Hong D, Zhu J, Chen
Z, Liu B, Liu H, Yang Q, Li H, et al: Predicting in-hospital
outcomes of patients with acute kidney injury. Nat Commun.
14:37392023. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wei S, Wu L, Xiang Z, Yang X, Pei D, Jiang
L and Du Z: EIF2AK2 protein targeted activation of AIM2-mediated
PANoptosis promotes sepsis-induced acute kidney injury. Ren Fail.
46:24036492024. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Lin SY, Chang CL, Liou KT, Kao YK, Wang
YH, Chang CC, Kuo TBJ, Huang HT, Yang CCH, Liaw CC and Shen YC: The
protective role of Achyranthes aspera extract against
cisplatininduced nephrotoxicity by alleviating oxidative stress,
inflammation, and PANoptosis. J Ethnopharmacol. 319:1170972024.
View Article : Google Scholar
|
|
112
|
You R: Mining biomarkers of acute kidney
injury in sepsis and preliminary exploration of the
PANoptosis-related mechanism. PhD dissertation. Peking Union
Medical College; 2023
|
|
113
|
Yan WT, Zhao WJ, Hu XM, Ban XX, Ning WY,
Wan H, Zhang Q and Xiong K: PANoptosis-like cell death in
ischemia/reperfusion injury of retinal neurons. Neural Regen Res.
18:357–363. 2023.
|
|
114
|
Wan H, Ban X, He Y, Yang Y, Hu X, Shang L,
Wan X, Zhang Q and Xiong K: Voltage-dependent anion channel 1
oligomerization regulates PANoptosis in retinal
ischemia-reperfusion injury. Neural Regen Res. 21:1652–1664. 2026.
View Article : Google Scholar
|
|
115
|
Yan WT, Yang YD, Hu XM, Ning WY, Liao LS,
Lu S, Zhao WJ, Zhang Q and Xiong K: Do pyroptosis, apoptosis, and
necroptosis (PANoptosis) exist in cerebral ischemia? Evidence from
cell and rodent studies. Neural Regen Res. 17:1761–1768. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Hamar P, Song E, Kökény G, Chen A, Ouyang
N and Lieberman J: Small interfering RNA targeting Fas protects
mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci
USA. 101:14883–14888. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zheng X, Zang G, Jiang J, He W, Johnston
NJ, Ling H, Chen R, Zhang X, Liu Y, Haig A, et al: Attenuating
ischemia-reperfusion injury in kidney transplantation by perfusing
donor organs with siRNA cocktail solution. Transplantation.
100:743–752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Basile DP, Liapis H and Hammerman MR:
Expression of bcl-2 and bax in regenerating rat renal tubules
following ischemic injury. Am J Physiol. 272:F640–F647.
1997.PubMed/NCBI
|
|
119
|
Thomas K, Zondler L, Ludwig N, Kardell M,
Lüneburg C, Henke K, Mersmann S, Margraf A, Spieker T, Tekath T, et
al: Glutamine prevents acute kidney injury by modulating oxidative
stress and apoptosis in tubular epithelial cells. JCI Insight.
7:e1631612022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yang B, Wang J, Qiao J, Zhang Q, Liu Q,
Tan Y, Wang Q, Sun W, Feng W, Li Z, et al: Circ DENND4C inhibits
pyroptosis and alleviates ischemia-reperfusion acute kidney injury
by exosomes secreted from human urine-derived stem cells. Chem Biol
Interact. 391:1109222024. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Tonnus W, Maremonti F, Belavgeni A, Latk
M, Kusunoki Y, Brucker A, von Mässenhausen A, Meyer C, Locke S,
Gembardt F, et al: Gasdermin D-deficient mice are hypersensitive to
acute kidney injury. Cell Death Dis. 13:7922022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Miao N, Yin F, Xie H, Wang Y, Xu Y, Shen
Y, Xu D, Yin J, Wang B, Zhou Z, et al: The cleavage of gasdermin D
by caspase-11 promotes tubular epithelial cell pyroptosis and
urinary IL-18 excretion in acute kidney injury. Kidney Int.
96:1105–1120. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Li T, Sun H, Li Y, Su L, Jiang J, Liu Y,
Jiang N, Huang R, Zhang J and Peng Z: Downregulation of macrophage
migration inhibitory factor attenuates NLRP3 inflammasome mediated
pyroptosis in sepsis-induced AKI. Cell Death Discov. 8:612022.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Linkermann A and Green DR: Necroptosis. N
Engl J Med. 370:455–465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Linkermann A, Bräsen JH, Himmerkus N, Liu
S, Huber TB, Kunzendorf U and Krautwald S: Rip1
(receptor-interacting protein kinase 1) mediates necroptosis and
contributes to renal ischemia/reperfusion injury. Kidney Int.
81:751–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Wang JN, Liu MM, Wang F, Wei B, Yang Q,
Cai YT, Chen X, Liu XQ, Jiang L, Li C, et al: RIPK1 inhibitor
Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via
attenuating necroptosis, inflammation and oxidative stress. Clin
Sci (Lond). 133:1609–1627. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Chen C, Xie J, Chen Z, Ye K, Wu C, Dai X,
Yuan Y, Lin Y, Wang Y, Chen H, et al: Role of Z-DNA binding protein
1 sensing mitochondrial Z-DNA and triggering necroptosis in
oxalate-induced acute kidney injury. J Am Soc Nephrol. 36:361–377.
2025. View Article : Google Scholar
|
|
128
|
He P, Ma Y, Wu Y, Zhou Q and Du H:
Exploring PANoptosis in breast cancer based on scRNA-seq and
bulk-seq. Front Endocrinol (Lausanne). 14:11649302023. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Chen G, He Z, Jiang W, Li L, Luo B, Wang X
and Zheng X: Construction of a machine learning-based artificial
neural network for discriminating PANoptosis related subgroups to
predict prognosis in low-grade gliomas. Sci Rep. 12:221192022.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Liu W, Liu Y, Chen S, Hui J and He S:
AURKB promotes immunogenicity and immune infiltration in clear cell
renal cell carcinoma. Discov Oncol. 15:2862024. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Choueiri TK and Motzer RJ: Systemic
therapy for metastatic renal-cell carcinoma. N Engl J Med.
376:354–366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Mall R, Bynigeri RR, Karki R, Malireddi
RKS, Sharma BR and Kanneganti TD: Pancancer transcriptomic
profiling identifies key PANoptosis markers as therapeutic targets
for oncology. NAR Cancer. 4:zcac0332022. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang Y, Zhou J, Zhang N, Zhu Y, Zhong Y,
Wang Z, Jin H and Wang X: A novel defined PANoptosis-related miRNA
signature for predicting the prognosis and immune characteristics
in clear cell renal cell carcinoma: A miRNA signature for the
prognosis of ccRCC. Int J Mol Sci. 24:93922023. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Liu W, Qu C and Wang X: Comprehensive
analysis of the role of immune-related PANoptosis lncRNA model in
renal clear cell carcinoma based on RNA transcriptome and
single-cell sequencing. Oncol Res. 31:543–567. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Xu Y, Hua J, Que H, Zeng T, Li Q, Deng J
and Xie J: Identification of PANoptosis-related signature reveals
immune infiltration characteristics and immunotherapy responses for
renal cell carcinoma. BMC Cancer. 24:2922024. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
GBD Chronic Kidney Disease Collaboration:
Global, regional, and national burden of chronic kidney disease,
1990-2017: A systematic analysis for the global burden of disease
study 2017. Lancet. 395:709–733. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Foreman KJ, Marquez N, Dolgert A, Fukutaki
K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW,
et al: Forecasting life expectancy, years of life lost, and
all-cause and cause-specific mortality for 250 causes of death:
Reference and alternative scenarios for 2016-40 for 195 countries
and territories. Lancet. 392:2052–2090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Lin Z, Chen A, Cui H, Shang R, Su T, Li X,
Wang K, Yang J, Gao K, Lv J, et al: Renal tubular epithelial cell
necroptosis promotes tubulointerstitial fibrosis in patients with
chronic kidney disease. FASEB J. 36:e226252022. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zhu Y, Cui H, Xia Y and Gan H:
RIPK3-mediated necroptosis and apoptosis contributes to renal
tubular cell progressive loss and chronic kidney disease
progression in rats. PLoS One. 11:e01567292016. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Pang Q, Wang P, Pan Y, Dong X, Zhou T,
Song X and Zhang A: Irisin protects against vascular calcification
by activating autophagy and inhibiting NLRP3-mediated vascular
smooth muscle cell pyroptosis in chronic kidney disease. Cell Death
Dis. 13:2832022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Xia Z, Wei Z, Li X, Liu Y, Gu X, Huang S,
Zhang X and Wang W: C/EBPα aggravates renal fibrosis in CKD through
the NOX4-ROS-apoptosis pathway in tubular epithelial cells. Biochim
Biophys Acta Mol Basis Dis. 1870:1670392024. View Article : Google Scholar
|
|
142
|
Liu X, Liu Z, Wang C, Miao J, Zhou S, Ren
Q, Jia N, Zhou L and Liu Y: Kidney tubular epithelial cells control
interstitial fibroblast fate by releasing TNFAIP8-encapsulated
exosomes. Cell Death Dis. 14:6722023. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Huang F, Wang Q, Guo F, Zhao Y, Ji L, An
T, Song Y, Liu Y, He Y and Qin G: FoxO1-mediated inhibition of
STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis
in diabetic kidney disease. EBioMedicine. 48:491–504. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Cao Y, Chen Z, Hu J, Feng J, Zhu Z, Fan Y,
Lin Q and Ding G: Mfn2 regulates high glucose-induced MAMs
dysfunction and apoptosis in podocytes via PERK pathway. Front Cell
Dev Biol. 9:7692132021. View Article : Google Scholar
|
|
145
|
Wang Y, Yu L, Li Y, Cha S, Shi L, Wang J,
Ge F, Huang C, Huang H, Tu Y, et al: Supplemented gegen qinlian
decoction formula attenuates podocyte mitochondrial fission and
renal fibrosis in diabetic kidney disease by inhibiting
TNF-α-mediated necroptosis, compared with empagliflozin. J
Ethnopharmacol. 334:1185722024. View Article : Google Scholar
|
|
146
|
Yu Q, Chen Y, Zhao Y, Huang S, Xin X,
Jiang L, Wang H, Wu W, Qu L, Xiang C, et al: Nephropathy is
aggravated by fatty acids in diabetic kidney disease through
tubular epithelial cell necroptosis and is alleviated by an RIPK-1
inhibitor. Kidney Dis (Basel). 9:408–423. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Shi Y, Chen X, Huang C and Pollock C:
RIPK3: A new player in renal fibrosis. Front Cell Dev Biol.
8:5022020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Hu B, Ma K, Wang W, Han Z, Chi M, Nasser
MI and Liu C: Research progress of pyroptosis in renal diseases.
Curr Med Chem. 31:6656–6671. 2024. View Article : Google Scholar
|
|
149
|
Liu P, Zhang Z and Li Y: Relevance of the
pyroptosis-related inflammasome pathway in the pathogenesis of
diabetic kidney disease. Front Immunol. 12:6034162021. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Zhang WT, Ge HW, Wei Y, Gao JL, Tian F and
Zhou EC: Molecular characterization of PANoptosis-related genes in
chronic kidney disease. PLoS One. 19:e03126962024. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Huang SC, Zhang L, Sung YS, Chen CL,
Krausz T, Dickson BC, Kao YC, Agaram NP, Fletcher CD and Antonescu
CR: Frequent FOS gene rearrangements in epithelioid hemangioma: A
molecular study of 58 cases with morphologic reappraisal. Am J Surg
Pathol. 39:1313–1321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Durchdewald M, Angel P and Hess J: The
transcription factor Fos: A Janus-type regulator in health and
disease. Histol Histopathol. 24:1451–1461. 2009.PubMed/NCBI
|
|
153
|
Huang YS, Lo CH, Tsai PH, Hou YC, Chang
YT, Guo CY, Hsieh HY, Lu KC, Shih HM and Wu CC: Downregulation of
AANAT by c-Fos in tubular epithelial cells with membranous
nephropathy. Biochem Biophys Res Commun. 584:32–38. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Wang F, Wang S, Wang J, Huang K, Chen G,
Peng Y, Liu C and Tao Y: Pharmacological mechanisms of Fuzheng
Huayu formula for Aristolochic acid I-induced kidney fibrosis
through network pharmacology. Front Pharmacol. 13:10568652022.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Yang G, Wang M, Qahar M, He J, Lai Z, Li
S, He D, Yan X, Xiong Z, Xiong Z and Le TH: Post-burns persistent
inflammation leads to kidney PANoptosis with caspases pathway
activation. Heliyon. 11:e414852024. View Article : Google Scholar
|
|
156
|
Lv Z, Hu J, Su H, Yu Q, Lang Y, Yang M,
Fan X, Liu Y, Liu B, Zhao Y, et al: TRAIL induces podocyte
PANoptosis via death receptor 5 in diabetic kidney disease. Kidney
Int. 107:317–331. 2025. View Article : Google Scholar
|
|
157
|
Zhang HR, Li YP, Shi ZJ, Liang QQ, Chen
SY, You YP, Yuan T, Xu R, Xu LH, Ouyang DY, et al: Triptolide
induces PANoptosis in macrophages and causes organ injury in mice.
Apoptosis. 28:1646–1665. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Xu C, Wang Q, Du C, Chen L, Zhou Z, Zhang
Z, Cai N, Li J, Huang C and Ma T: Histone deacetylase-mediated
silencing of PSTPIP2 expression contributes to aristolochic acid
nephropathy-induced PANoptosis. Br J Pharmacol. 181:1452–1473.
2024. View Article : Google Scholar
|
|
159
|
Yuan F, Cai J, Wu J, Tang Y, Zhao K, Liang
F, Li F, Yang X, He Z, Billiar TR, et al: Z-DNA binding protein 1
promotes heatstroke-induced cell death. Science. 376:609–615. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Sanz AB, Sanchez-Niño MD, Ramos AM and
Ortiz A: Regulated cell death pathways in kidney disease. Nat Rev
Nephrol. 19:281–299. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Ruiz-Ortega M, Rayego-Mateos S, Lamas S,
Ortiz A and Rodrigues-Diez RR: Targeting the progression of chronic
kidney disease. Nat Rev Nephrol. 16:269–288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Weisel K, Berger S, Thorn K, Taylor PC,
Peterfy C, Siddall H, Tompson D, Wang S, Quattrocchi E, Burriss SW,
et al: A randomized, placebo-controlled experimental medicine study
of RIPK1 inhibitor GSK2982772 in patients with moderate to severe
rheumatoid arthritis. Arthritis Res Ther. 23:852021. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Weisel K, Scott N, Berger S, Wang S, Brown
K, Powell M, Broer M, Watts C, Tompson DJ, Burriss SW, et al: A
randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772
in patients with active ulcerative colitis. BMJ Open Gastroenterol.
8:e0006802021. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Shiffman M, Freilich B, Vuppalanchi R,
Watt K, Chan JL, Spada A, Hagerty DT and Schiff E: Randomised
clinical trial: emricasan versus placebo significantly decreases
ALT and caspase 3/7 activation in subjects with non-alcoholic fatty
liver disease. Aliment Pharmacol Ther. 49:64–73. 2019. View Article : Google Scholar
|
|
165
|
Ludbrook VJ, Budd DC, Thorn K, Tompson D,
Votta BJ, Walker L, Lee A, Chen X, Peppercorn A and Loo WJ:
Inhibition of receptor-interacting protein kinase 1 in chronic
plaque psoriasis: A multicenter, randomized, double-blind,
placebo-controlled study. Dermatol Ther (Heidelb). 14:489–504.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Weisel K, Berger S, Papp K, Maari C,
Krueger JG, Scott N, Tompson D, Wang S, Simeoni M, Bertin J and
Peter Tak P: Response to inhibition of receptor-interacting protein
kinase 1 (RIPK1) in active plaque psoriasis: A randomized
placebo-controlled study. Clin Pharmacol Ther. 108:808–816. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Karki R, Sundaram B, Sharma BR, Lee S,
Malireddi RKS, Nguyen LN, Christgen S, Zheng M, Wang Y, Samir P, et
al: ADAR1 restricts ZBP1-mediated immune response and PANoptosis to
promote tumorigenesis. Cell Rep. 37:1098582021. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Oh S, Lee J, Oh J, Yu G, Ryu H, Kim D and
Lee S: Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation
and assembly drive PANoptosis. Cell Mol Immunol. 20:1513–1526.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Huang R, Hu Y, Wang YF, Zhang S, Wang ZG,
Pang DW and Liu SL: Targeted degradation of ZBP1 with covalent
PROTACs for anti-inflammatory treatment of infections. Angew Chem
Int Ed Engl. 64:e2024235242025. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhang T, Yin C, Fedorov A, Qiao L, Bao H,
Beknazarov N, Wang S, Gautam A, Williams RM, Crawford JC, et al:
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven
necroptosis. Nature. 606:594–602. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Yang W, Tao K, Wang Y, Huang Y, Duan C,
Wang T, Li C, Zhang P, Yin Y, Gao J and Li R: Necrosulfonamide
ameliorates intestinal inflammation via inhibiting GSDMD-medicated
pyroptosis and MLKL-mediated necroptosis. Biochem Pharmacol.
206:1153382022. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Green JP, El-Sharkawy LY, Roth S, Zhu J,
Cao J, Leach AG, Liesz A, Freeman S and Brough D: Discovery of an
inhibitor of DNA-driven inflammation that preferentially targets
the AIM2 inflammasome. iScience. 26:1067582023. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Lin Q, Li S, Jiang N, Jin H, Shao X, Zhu
X, Wu J, Zhang M, Zhang Z, Shen J, et al: Inhibiting NLRP3
inflammasome attenuates apoptosis in contrast-induced acute kidney
injury through the upregulation of HIF1A and BNIP3-mediated
mitophagy. Autophagy. 17:2975–2990. 2021. View Article : Google Scholar :
|
|
174
|
Li C, Yang H, Wu Y, Zhou M, Luo H, Yuan P
and Shen F: Carnosol alleviates cisplatin-induced acute kidney
injury by regulating apoptosis and pyroptosis. Cell Biol Int.
49:101–117. 2025. View Article : Google Scholar
|
|
175
|
Chen L, Fang H, Li X, Yu P, Guan Y, Xiao
C, Deng Z, Hei Z, Chen C and Luo C: Connexin32 gap junction
channels deliver miR155-3p to mediate pyroptosis in renal
ischemia-reperfusion injury. Cell Commun Signal. 22:1212024.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Li J, Lin Q, Shao X, Li S, Zhu X, Wu J,
Mou S, Gu L, Wang Q, Zhang M, et al: HIF1α-BNIP3-mediated mitophagy
protects against renal fibrosis by decreasing ROS and inhibiting
activation of the NLRP3 inflammasome. Cell Death Dis. 14:2002023.
View Article : Google Scholar
|
|
177
|
Ji Y, Hua H, Jia Z, Zhang A and Ding G:
Therapy targeted to the NLRP3 inflammasome in chronic kidney
disease. Kidney Dis (Basel). 10:369–383. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Østergaard JA, Jha JC, Sharma A, Dai A,
Choi JSY, de Haan JB, Cooper ME and Jandeleit-Dahm K: Adverse renal
effects of NLRP3 inflammasome inhibition by MCC950 in an
interventional model of diabetic kidney disease. Clin Sci (Lond).
136:167–180. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Wu M, Yang Z, Zhang C and Shi Y, Han W,
Song S, Mu L, Du C and Shi Y: Inhibition of NLRP3 inflammasome
ameliorates podocyte damage by suppressing lipid accumulation in
diabetic nephropathy. Metabolism. 118:1547482021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Chen YM, Tang BX, Chen WY and Zhao MS:
Ursolic acid inhibits the invasiveness of A498 cells via NLRP3
inflammasome activation. Oncol Lett. 20:1702020. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Klück V, Jansen TLTA, Janssen M,
Comarniceanu A, Efdé M, Tengesdal IW, Schraa K, Cleophas MCP,
Scribner CL, Skouras DB, et al: Dapansutrile, an oral selective
NLRP3 inflammasome inhibitor, for treatment of gout flares: An
open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet
Rheumatol. 2:e270–e280. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Yin P, Jia J, Li J, Song Y, Zhang Y and
Chen F: ABT-737, a Bcl-2 selective inhibitor, and chloroquine
synergistically kill renal cancer cells. Oncol Res. 24:65–72. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Sun H, Wang W, Che Y and Jiang X: Fungal
secondary metabolites rasfonin induces autophagy, apoptosis and
necroptosis in renal cancer cell line. Mycology. 7:81–87. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Ding Z, Zhao J, Wang X, Li W, Chen C, Yong
C, Zhu Y, Tian F, Liu L, Yu M, et al: Total extract of Abelmoschus
manihot L. alleviates uric acid-induced renal tubular epithelial
injury via inhibition of caspase-8/caspase-3/NLRP3/GSDME signaling.
Front Pharmacol. 13:9079802022. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Li X, Hu D, Li Y, Luo Y, Liang B, Yu K,
Xiong W and Zuo D: Overexpression of TP53INP2 promotes apoptosis in
clear cell renal cell cancer via caspase-8/TRAF6 signaling pathway.
J Immunol Res. 2022:12604232022.PubMed/NCBI
|
|
186
|
Gautam A, Boyd DF, Nikhar S, Zhang T,
Siokas I, Van de Velde LA, Gaevert J, Meliopoulos V, Thapa B,
Rodriguez DA, et al: Necroptosis blockade prevents lung injury in
severe influenza. Nature. 628:835–843. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Abou Taha MA, Ali FEM, Saleh IG and Akool
ES: Sorafenib and edaravone protect against renal fibrosis induced
by unilateral ureteral obstruction via inhibition of oxidative
stress, inflammation, and RIPK-3/MLKL pathway. Naunyn Schmiedebergs
Arch Pharmacol. 397:8961–8977. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Hou Y, Feng Q, Wei C, Cao F, Liu D, Pan S,
Shi Y, Liu Z and Liu F: Emerging role of PANoptosis in kidney
diseases: Molecular mechanisms and therapeutic opportunities.
Apoptosis. 30:579–596. 2025. View Article : Google Scholar : PubMed/NCBI
|
